Sunday February 16, 2014
Pharmaceutical sales in India are expected to rise by 14.4 per cent to $27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, consultancy fi...
Wednesday February 12, 2014
"Unfortunately, the many Indian companies that understand good manufacturing and quality processes have been overshadowed by recent lapses in quality at a handful of pharmaceutical firms," Hamburg, currently on an India trip, said in a blog posted on...
Wednesday February 12, 2014
The US Food and Drug Administration plans to conduct workshops across India in the next one year in order to sanitise the countrys pharmaceutical companies about the changing quality requirements in the American market.
Monday February 10, 2014
Shares of Indian pharmaceutical companies perceived as defensive gain on risk aversion after overseas investors sold Rs 267 crore worth of Indian shares on Friday, extending their selling streak to a seventh day, provisional exchange data shows, deal...
Thursday February 6, 2014
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
Sunday January 12, 2014
Pharmaceutical companies may witness a core sales growth of 26 per cent in the third quarter of fiscal year 2014, according to a report by Bank of America-Merrill Lynch.
Sunday December 29, 2013
Implementation of the new pricing policy is likely to translate into weak domestic revenue generation for pharma companies in 2014, according to a report by global research firm Dun & Bradstreet.
Wednesday December 11, 2013
In a statement, the Commission's antitrust chief, Joaquin Almunia, said the two companies "shockingly deprived patients in the Netherlands, including people suffering from cancer, from access to a cheaper version of this medicine."
Thursday November 28, 2013
The pharma industry in India has clocked double digit growth rate (about 14 per cent) in the last five years and this is expected to continue in 2014 too. Several multinational firms operate in this space, which has great scope for hiring and job cre...
Sandeep Phukan | Monday November 25, 2013
The Cabinet will decide on FDI limit in existing pharmaceutical companies producing critical medicines.
Sunday November 24, 2013
Monaco government has invited Indian companies to invest in various sectors, including information technology, pharmaceuticals and real estate.
Tuesday October 22, 2013
Symbiotec is a leading specialist producer of steroid- hormone active pharmaceutical ingredients and has over 200 customers, including large multinationals as well as generic pharmaceutical companies, Actis said in a statement.
Friday October 18, 2013
A barcode helps in tracking and tracing of origin of drugs, which in turn helps in minimising the chances of genuine drugs being considered spurious, sub-standard or counterfeit.
Sunday September 29, 2013
The National Pharmaceutical Pricing Authority (NPPA) said it has been receiving representations from manufacturers seeking clarifications and corrections mainly with regard to applicability of price notifications on their products as well as regardin...
Friday August 30, 2013
In its latest action against Indian drug makers, the US health regulator FDA had red- flagged "significant deviations" from good manufacturing practices by two Indian pharmaceutical companies: Hyderabad-based Posh Chemicals and Himachal Pradesh-based...
Sunday August 11, 2013
Many Indian drug makers will soon have to bear higher costs for sale of products in American markets, as the US Food and Drug Administration (FDA) is hiking the fees for generic drug makers by up to 48 per cent from October.
Wednesday July 10, 2013
The BSE Sensex is flat as the rupee fails to gain after the Reserve Bank of India (RBI) asked state-run oil companies to purchase dollars from a single bank - a measure that is seen providing only near-term support.
Sunday June 23, 2013
In a bid to strengthen their hybrid business model, drug major Ranbaxy Laboratories and its parent firm Daiichi Sankyo will project only one of them as the face of the group in different global markets depending on their respective strengths.
Miloni Bhatt | Tuesday June 4, 2013
The EU claims Ranbaxy and other international pharmaceutical companies blocked the delivery of cheap drugs to the EU market, despite an agreement to deliver. Also, European regulators have estimated that consumers are paying up to 20 per cent more fo...
Tuesday June 4, 2013
Shares in pharmaceutical companies are leading the gains on Tuesday due to factors such as value-buying and expectations that promoters may increase stake in some companies, dealers say.